BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26392009)

  • 1. Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.
    Felicetti P; Trotta F; Bonetto C; Santuccio C; Brauchli Pernus Y; Burgner D; Chandler R; Girolomoni G; Hadden RD; Kochhar S; Kucuku M; Monaco G; Ozen S; Pahud B; Phuong L; Bachtiar NS; Teeba A; Top K; Varricchio F; Wise RP; Zanoni G; Živkovic S; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6634-6640. PubMed ID: 26392009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
    Masuka JT; Khoza S
    BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculitis as an adverse event following immunization - Systematic literature review.
    Bonetto C; Trotta F; Felicetti P; Alarcón GS; Santuccio C; Bachtiar NS; Brauchli Pernus Y; Chandler R; Girolomoni G; Hadden RD; Kucuku M; Ozen S; Pahud B; Top K; Varricchio F; Wise RP; Zanoni G; Živković S; Bonhoeffer J;
    Vaccine; 2016 Dec; 34(51):6641-6651. PubMed ID: 26398442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study.
    Hoeve CE; van Haren A; Sturkenboom MCJM; Straus SMJM
    Vaccine; 2018 Dec; 36(52):7956-7964. PubMed ID: 30416019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
    Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D; Cook J; Dey A; Macartney K; Menzies RI
    Commun Dis Intell Q Rep; 2012 Dec; 36(4):E315-32. PubMed ID: 23330706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
    Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
    Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.
    Hibbs BF; Moro PL; Lewis P; Miller ER; Shimabukuro TT
    Vaccine; 2015 Jun; 33(28):3171-8. PubMed ID: 25980429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
    Martin D; Menschik D; Bryant-Genevier M; Ball R
    Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Loughlin AM; Marchant CD; Adams W; Barnett E; Baxter R; Black S; Casey C; Dekker C; Edwards KM; Klein J; Klein NP; LaRussa P; Sparks R; Jakob K
    Vaccine; 2012 Nov; 30(50):7253-9. PubMed ID: 23063829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of human papilloma virus vaccines: an analysis of the US Vaccine Adverse Event Reporting System from 2007 to 2017.
    Bonaldo G; Vaccheri A; D'Annibali O; Motola D
    Br J Clin Pharmacol; 2019 Mar; 85(3):634-643. PubMed ID: 30569481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual report: surveillance of adverse events following immunisation in Australia, 2008.
    Menzies R; Mahajan D; Gold MS; Roomiani I; McIntyre P; Lawrence G
    Commun Dis Intell Q Rep; 2009 Dec; 33(4):365-81. PubMed ID: 20301966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European data.
    Bonaldo G; Noseda R; Ceschi A; Vaccheri A; Motola D
    Sci Rep; 2020 Aug; 10(1):13601. PubMed ID: 32788620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
    Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
    Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for adverse events following immunization (AEFI) for 7 years using a computerised vaccination system.
    Alguacil-Ramos AM; Muelas-Tirado J; Garrigues-Pelufo TM; Portero-Alonso A; Diez-Domingo J; Pastor-Villalba E; Lluch-Rodrigo JA
    Public Health; 2016 Jun; 135():66-74. PubMed ID: 26976484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.
    Iqbal S; Shi J; Seib K; Lewis P; Moro PL; Woo EJ; Shimabukuro T; Orenstein WA
    Lancet Infect Dis; 2015 Oct; 15(10):1175-1182. PubMed ID: 26289956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing.
    Crooks CJ; Prieto-Merino D; Evans SJ
    Drug Saf; 2012 Jan; 35(1):61-78. PubMed ID: 22136183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki disease after vaccination: reports to the vaccine adverse event reporting system 1990-2007.
    Hua W; Izurieta HS; Slade B; Belay ED; Haber P; Tiernan R; Woo EJ; Iskander J; Braun MM; Ball R
    Pediatr Infect Dis J; 2009 Nov; 28(11):943-7. PubMed ID: 19755926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No signal of interactions between influenza vaccines and drugs used for chronic diseases: a case-by-case analysis of the vaccine adverse event reporting system and vigibase.
    Carnovale C; Raschi E; Leonardi L; Moretti U; De Ponti F; Gentili M; Pozzi M; Clementi E; Poluzzi E; Radice S
    Expert Rev Vaccines; 2018 Apr; 17(4):363-381. PubMed ID: 29452497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.